Stock screener

CRSP

Conviction 56HealthcareScan · Thu, Jun 25, 2026
CRSP$54.00+0.84%
ResistanceSupportVol 14Insider sell
63 bars
Vol MA14 1.71M
Mar 26Apr 14May 1May 19Jun 8Jun 25
WSB mentions · 24h changelatest -50.00%· 2 mentions
Mar 26Apr 14May 1May 19Jun 8Jun 25
CRISPR Therapeutics AGBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.crisprtx.com ↗
Price54.00
Change+0.84%
Gap+1.31%
Rel volume2.28×
Avg volume1.79M
Avg $ vol95.81M
SMA 2053.00
SMA 5052.77
SMA 20055.54
Price vs 50+2.33%
Price vs 200-2.77%
MA stackmixed
50/200 cross—
Supertrendup · 47.46
RSI (14)54
MACD hist0.24
MACD crossbull · 5d
Stoch %K / %D66 / 54
ADX (14)20
+DI / −DI24 / 13
RSI divergence—
MACD divergence—
ATR %+5.16%
ADR %5.28%
52w high76.78
52w low44.34
From 52w high-29.67%
Above 52w low+21.79%
New 52w highNo
SqueezeOff
Bollinger width15.38%
%B0.62
Donchian pos49.90%
Donchian high59.00
Donchian low49.02
AVWAP (52w high)55.45
vs AVWAP high-2.61%
AVWAP (52w low)52.61
vs AVWAP low+2.65%
OBV trendFlat
Chaikin MF (20)-0.17
Today vs 20d2.28×
Avg vol (14d)1.71M
Avg vol (20d)1.79M
Avg $ vol (20d)95.81M
Market cap5.21B
RS 3m (vs SPY)+3.08%
RS 6m (vs SPY)-11.87%
RS line new highNo
Trend template2/8
Technical rank43.9
1 week+1.71%
1 month+4.67%
3 months+14.67%
6 months-6.75%
1 year+15.43%
YTD+0.43%
P/E-8.96
P/B2.87
P/S—
P/FCF-15.06
EPS-6.47
Div yield—
ROE-32.05%
ROA-21.34%
Debt/Eq0.32
Current17.96
EV/EBITDA-8.32
Gross margin—
Net margin—
Rev growth-90.59%
EPS growth-58.80%
Price target73.85
Target upside36.76%
Analyst ratingBuy
Institutional83.06%
Ent. value5.37B
Revenue1.46M
Net income-122.93M
Gross profit—
Free cash flow-345.93M
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
ExchangeNasdaq
Shares out96.45M
Employees393
ListedWed, Oct 19, 2016
Free float82.71M
Float %86.2%
Short interest21.67M
Days to cover12.3d
Short volume47.3%
Squeeze score85 / 100
Next earningsMon, Aug 3, 2026 (39d)
EPS forecast−$1.13 · 8 est
Last EPS vs est−$1.28 vs −$1.14
Last surprise-12.3% miss
Setup gradeC
Conviction56 / 100
Pattern quality—
Tech rank43.9 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance58.12
Support47.97
Days since event—
Candle confirm—
News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in CRSP

All disclosures →
No recent disclosed trades by Congress in CRSP. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in CRSP · 10 buys

InsiderSideShares
Morrison Briggs
Director · Stock Option (Right to Buy) · 2026-06-05
Grant13K
George Simeon
Director · Stock Option (Right to Buy) · 2026-06-05
Grant13K
Behbahani Ali
Director · Stock Option (Right to Buy) · 2026-06-05
Grant13K
Greene John
Director · Stock Option (Right to Buy) · 2026-06-05
Grant13K
Treco Douglas A
Director · Stock Option (Right to Buy) · 2026-06-05
Grant13K
Rommel Christian
Director · Stock Option (Right to Buy) · 2026-06-05
Grant13K
Fleming Harold Edward
Director · Stock Option (Right to Buy) · 2026-06-05
Grant13K
High Katherine A
Director · Stock Option (Right to Buy) · 2026-06-05
Grant13K
Mahatme Sandesh
Director · Stock Option (Right to Buy) · 2026-06-05
Grant13K
Fardis Maria
Director · Stock Option (Right to Buy) · 2026-06-05
Grant13K

SEC filings

EDGAR filings in CRSP · 1 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.